![](/img/cover-not-exists.png)
Clinical benefit of treatment with eribulin mesylate for metastatic triple-negative breast cancer: Long-term outcomes of patients treated in the US community oncology setting
Mougalian, Sarah S., Copher, Ronda, Kish, Jonathan K., McAllister, Lindsay, Wang, Zhixiao, Broscious, Mary, Garofalo, David, Radtchenko, Janna, Feinberg, Bruce A.Language:
english
Journal:
Cancer Medicine
DOI:
10.1002/cam4.1705
Date:
July, 2018
File:
PDF, 194 KB
english, 2018